Meta-Analysis of Hematological Biomarkers as Reliable Indicators of Soft Tissue Sarcoma Prognosis
Background: Several recent studies have reported the reliable prognostic effect of hematological biomarkers in various tumors. Yet, the prognostic value of these hematological markers in soft tissue sarcoma (STS) remains inconclusive. Thus, the aim of this meta-analysis was to check the effect of he...
Main Authors: | Long-Qing Li, Zhen-Hua Bai, Liang-Hao Zhang, Yan Zhang, Xin-Chang Lu, Yi Zhang, Yong-Kui Liu, Jia Wen, Jia-Zhen Li |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2020-01-01
|
Series: | Frontiers in Oncology |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fonc.2020.00030/full |
Similar Items
-
Integrative Clustering Reveals a Novel Subtype of Soft Tissue Sarcoma With Poor Prognosis
by: Zhenhua Zhu, et al.
Published: (2020-02-01) -
Assessing Prognostic and Predictive Biomarkers of Regorafenib Response in Patients with Advanced Soft Tissue Sarcoma: REGOSARC Study
by: Thomas Brodowicz, et al.
Published: (2020-12-01) -
Assessment of Efficiency and Safety of Apatinib in Advanced Bone and Soft Tissue Sarcomas: A Systematic Review and Meta-Analysis
by: Zuoyao Long, et al.
Published: (2021-03-01) -
Bioinformatics analysis reveals the competing endogenous RNA (ceRNA) coexpression network in the tumor microenvironment and prognostic biomarkers in soft tissue sarcomas
by: Dandan Zou, et al.
Published: (2021-01-01) -
Treatment Outcomes and Prognostic Factors of Pulmonary Metastasectomy for Bone and Soft Tissue Sarcoma: a High Volume Academic Institution Experience
by: Xiaozheng KANG, et al.
Published: (2016-05-01)